Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

While bisphosphonates are indicated for prevention of skeletal-related events, radionuclide therapy is widely used for treatment of painful bone metastases. Combined radionuclide therapy with bisphosphonates has demonstrated improved effectiveness in achieving bone pain palliation in comparison to m...

Full description

Saved in:
Bibliographic Details
Main Authors: Nigora Rasulova, Vladimir Lyubshin, Dauranbek Arybzhanov, Sh. Sagdullaev, Valery Krylov, Marat Khodjibekov
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Bone pain palliation
Sm-153 oxabifore
Zoledronic acid
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2013;volume=12;issue=1;spage=14;epage=18;aulast=Rasulova
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items